Author (Corporate) | European Medicines Agency |
---|---|
Series Title | Press Release |
Series Details | EMEA/385013/2005 (17.11.05) |
Publication Date | 17/11/2005 |
Content Type | News |
Tamiflu is an antiviral approved in the European Union for the treatment of influenza in children between the ages of 1 and 13 years of age and for the prevention and treatment of influenza in adolescents over 13 years and adults. |
|
Source Link | Link to Main Source http://www.emea.europa.eu/pdfs/general/direct/pr/38501305en.pdf |
Related Links |
|
Subject Categories | Health |
Countries / Regions | Europe |